Why the study?
Standardization of critical clinical and angiographic endpoints is needed to enable the interpretability and comparability of different device trials.
Key points are not available for this paper at this time.
Design
Review
May improve comparability of device trial results for clinicians; leaves open broader adoption to confirm research benefits.
Standardization of the most critical clinical and angiographic endpoints enables interpretability and comparability of different device trials. Since 2006, the Academic Research Consortium (ARC) group has taken the lead in gathering major stakeholders, such as the Standardized Data Collection for Cardiovascular Trials Initiative (SCTI), the Universal Definition of Myocardial Infarction (UDMI), and the Society for Cardiovascular Angiography and Interventions (SCAI), in order to agree on common definitions. As a result, consensus does exist regarding the essential definitions and reporting process for death, myocardial infarction, stroke, bleeding, or repeat revascularization.
No takes yet. Share an insight, caveat, or question.
Tóth et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: